Advanced search
Publication Cover
Acta Orthopaedica Volume 83, 2012 - Issue 6
Journal homepage
1,556
Views
35
CrossRef citations to date
0
Altmetric
Fracture

Screening for osteoporosis reduced new fracture incidence by almost half

A 6-year follow-up of 592 fracture patients from an osteoporosis screening program

Jörgen ÅstrandOrthopaedics Unit, Department of Clinical Sciences, Medical Faculty, Lund University, SwedenCorrespondence[email protected]
,
Johan NilssonOrthopaedics Unit, Department of Clinical Sciences, Medical Faculty, Lund University, Sweden
&
Karl-Göran ThorngrenOrthopaedics Unit, Department of Clinical Sciences, Medical Faculty, Lund University, Sweden
Pages 661-665 | Received 17 Feb 2012, Accepted 13 Jul 2012, Published online: 11 Nov 2012

  • Astrand J, Thorngren KG, Tagil M. One fracture is enough! Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients. Acta Orthop 2006; 77 (1): 3-8.
  • Astrand J, Thorngren KG, Tagil M, Akesson K. 3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care! Acta Orthop 2008; 79 (3): 404-9.
  • Barr RJ, Stewart A, Torgerson DJ, Reid DM. Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos Int 2010; 21 (4): 561-8.
  • Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, . Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 7, 348 (9041): 1535-41.
  • Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, . Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006; 27, 296 (24): 2927-38.
  • Blake GM, Fogelman I. Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom 2007; 10 (1): 102-10.
  • Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 2002; 13 (6): 450-5.
  • Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J Endocrinol Invest 2004; 27 (1): 99-105.
  • Edwards BJ, Bunta AD, Madison LD, DeSantis A, Ramsey-Goldman R, Taft L, . An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf 2005; 31 (5): 267-74.
  • Freedman BA, Potter BK, Nesti LJ, Cho T, Kuklo TR. Missed opportunities in patients with osteoporosis and distal radius fractures. Clin Orthop 2007; (454): 202-6.
  • Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, . Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 2007; 18 (1): 69-76.
  • Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993; 52 (4): 269-72.
  • McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003; 14 (12): 1028-34.
  • Mulder JE, Kolatkar NS, LeBoff MS. Drug insight: Existing and emerging therapies for osteoporosis. Nat Clin Pract Endocrinol Metab 2006; 2 (12): 670-80.
  • Nordin C. Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2011; 16, 155 (4): 276.
  • Nurmi-Luthje I, Luthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, . Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging 2009; 26 (5): 409-21.
  • Nurmi-Luthje I, Sund R, Juntunen M, Luthje P. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Miner Res 2011; 26 (8): 1845-53.
  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002; 17, 288 (3): 321-33.
  • Roux C, Cooper C, Diez-Perez A, Martinez L, Ortolani S, Gitlin M, . Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study. Osteoporos Int 2011; 22 (4): 1227-36.
  • Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg (Am) 2008; 90 (6): 1197-205.
  • Stein CM, Ray WA. The ethics of placebo in studies with fracture end points in osteoporosis. N Engl J Med 2010; 30, 363 (14): 1367-70.
  • Wagner H, Melhus H, Gedeborg R, Pedersen NL, Michaelsson K. Simply ask them about their balance--future fracture risk in a nationwide cohort study of twins. Am J Epidemiol 2009; 15, 169 (2): 143-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.